Related Experiment Videos
LAGE-1, a new gene with tumor specificity
1Ludwig Institute for Cancer Research, Brussels Branch, Université Catholique de Louvain. lethe@licr.ucl.ac.be
International Journal of Cancer
|June 17, 1998
Summary
Researchers identified LAGE-1, a novel gene expressed in various cancers but not normal skin, except for testis. Its expression correlates with NY-ESO-1 and MAGE genes, suggesting potential diagnostic and therapeutic applications.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Tumor-specific gene expression is crucial for cancer research.
- Identifying novel cancer-associated genes can lead to new diagnostic and therapeutic strategies.
Purpose of the Study:
- To identify and characterize novel genes expressed in human melanoma.
- To investigate the expression patterns and potential functions of the identified gene, LAGE-1.
Main Methods:
- Representational difference analysis (RDA) to compare gene expression between melanoma and normal skin.
- cDNA library screening and gene sequencing.
- Gene mapping (Xq28), analysis of alternative splicing, and expression profiling in various tumor types and normal tissues.
Main Results:
- A novel gene, LAGE-1, was identified and sequenced.
- LAGE-1 maps to Xq28 and produces two distinct protein isoforms via alternative splicing.
- LAGE-1 is expressed in 25-50% of melanomas and other cancers (lung, bladder, prostate, head and neck), with restricted normal tissue expression in the testis.
- LAGE-1 expression is induced by deoxy-azacytidine, suggesting epigenetic regulation (demethylation).
- LAGE-1 expression strongly correlates with NY-ESO-1 and MAGE gene expression.
Conclusions:
- LAGE-1 is a novel tumor-associated gene with potential as a biomarker.
- Its expression pattern and correlation with other cancer-testis antigens suggest a role in oncogenesis.
- Epigenetic mechanisms, such as demethylation, likely regulate LAGE-1 expression in tumors.